Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Results from Rat Study May Lead to Prevention of Cocaine Addiction in Humans

By BiotechDaily International staff writers
Posted on 01 Apr 2013
Print article
Disruption of a "feed-forward loop" that links the activities of two enzymes in the nucleus accumbens region of the brain of cocaine addicts prevented or reversed addiction to the drug in a rodent model and in tissues taken from deceased human subjects.

The transcription factor delta-FosB and the brain-enriched calcium/calmodulin-dependent protein kinase II (CaMKII-alpha) were induced in the nucleus accumbens (NAc) by chronic exposure to cocaine or other psychostimulant drugs of abuse.

Investigators at Michigan State University (East Lansing, USA) reported in the March 6, 2013, issue of the Journal of Neuroscience that delta-FosB was phosphorylated by CaMKII-alpha at the protein-stabilizing serine-27 residue, and that CaMKII-alpha was required for the cocaine-mediated accumulation of delta-FosB in rat NAc. Conversely, they showed that delta-FosB was both necessary and sufficient for cocaine induction of CaMKII-alpha gene expression in vivo.

The current study further demonstrated the induction of delta-FosB and CaMKII-alpha in the NAc of human cocaine addicts, suggesting possible targets for future therapeutic intervention. These results suggest that delta-FosB and CaMKII-alpha engaged in a cell-type- and brain-region-specific positive feed-forward loop as a key mechanism for regulating the reward circuitry of the brain in response to chronic cocaine.

“Understanding what happens molecularly to this brain region during long-term exposure to drugs might give us insight into how addiction occurs,” said first author Dr. A.J. Robison, assistant professor in the physiology at Michigan State University. “The increased production of these proteins that we found in the animals exposed to drugs was exactly paralleled in a population of human cocaine addicts. That makes us believe that the further experiments and manipulations we did in the animals are directly relevant to humans.”

Related Links:
Michigan State University




Print article

Channels

Drug Discovery

view channel
Image: A scanning electron microscope (SEM) image of methicillin-resistant Staphylococcus aureus bacteria (Photo courtesy of the CDC).

Drug Combination Cures MRSA Infection While Preventing Development of Resistance

Treatment with a combination comprising the well-known antibiotic cefdinir and the experimental drug TXA709 cured mice of drug-resistant staphylococcal infections while reducing the development of resistance.... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel
Image: A three-dimensional printer adapted for stem cell production (Photo courtesy of Nano Dimension).

Israeli Developers Demonstrate Prototype Three-Dimensional Bioprinter

Two Israeli companies have combined efforts in the development of three-dimensional printer technology for the production of stem cells. The three-dimensional print electronics developer Nano Dimension... Read more

Business

view channel

Acquisition to Boost Development of Drugs for Neurogenic Conditions

According to a recent announcement, a privately held biotechnology/drug development company is to be acquired by one of the major pharmaceutical manufacturers. The drug manufacturer Merck & Co. (Kenilworth, NJ, USA) has agreed to pay 500 million USD up front for Afferent Pharmaceuticals (San Mateo, CA, USA) and up... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.